First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients with Advanced Solid Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

First-In-Human Phase I Study of Lurbinectedin (PM01183) in Patients with Advanced Solid Tumors

Published:2014-02-21 Issue:8 Volume:20 Page:2205-2214
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Elez María Elena,Tabernero Josep,Geary David,Macarulla Teresa,Kang S. Peter,Kahatt Carmen,Pita Arturo Soto-Matos,Teruel Carlos Fernandez,Siguero Mariano,Cullell-Young Martin,Szyldergemajn Sergio,Ratain Mark J.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety and Efficacy of the Combination Lurbinectedin plus Doxorubicin from a Phase 1b Trial in Patients with Advanced/Metastatic Soft-Tissue Sarcoma;Clinical Cancer Research;2024-05-09

2. Pharmacokinetics and Safety of Lurbinectedin Administrated with Itraconazole in Cancer Patients: A Drug–Drug Interaction Study;Marine Drugs;2024-04-16

3. A Comprehensive Review on the Role of Lurbinectedin in Soft Tissue Sarcomas;Current Treatment Options in Oncology;2024-02

4. Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinectedin Pharmacokinetics and Safety in Patients with Advanced Solid Tumors: An Open-Label, Two-Way, Crossover, Phase Ib Drug–Drug Interaction Study;Pharmaceuticals;2024-01-30

5. Drug from Marine Sampling to Factory;Marine Ecology: Current and Future Developments;2023-11-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP